Web Stats Provided By Google Analytics

Thursday, August 15, 2013

Inovio Malaria DNA Vaccine Demonstrates Robust Immune Responses in Animal Models

Inovio Pharmaceuticals, Inc. announced today that its SynConA DNA vaccine containing multiple malaria antigens delivered via its CELLECTRAA electroporation device demonstrated strong and durable antibody and T-cell immune responses in small animals and non-human primates.

http://www.benzinga.com/news/13/08/3840799/inovio-malaria-dna-vaccine-demonstrates-robust-immune-responses-in-animal-models

No comments:

Post a Comment